Clinical Trial
Accepted on 26 Aug 2024
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial
in Pediatric Nephrology
Clinical Trial
Accepted on 26 Aug 2024
in Pediatric Nephrology
Original Research
Accepted on 26 Aug 2024
in Atmospheric Science
Editorial
Accepted on 26 Aug 2024
in Sports Science, Technology and Engineering
Original Research
Accepted on 26 Aug 2024
in Molecular and Cellular Pathology
Review
Accepted on 26 Aug 2024
in Addictive Behaviors
Original Research
Accepted on 26 Aug 2024
in Lipids in Cardiovascular Disease
Original Research
Accepted on 26 Aug 2024
in Educational Psychology
Original Research
Accepted on 26 Aug 2024
in Cardiac Electrophysiology
Original Research
Accepted on 26 Aug 2024
in Public Health Policy
Original Research
Accepted on 26 Aug 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 26 Aug 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 26 Aug 2024
in Preventive Dentistry
Systematic Review
Accepted on 26 Aug 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 26 Aug 2024
in Gastrointestinal Sciences
Review
Accepted on 26 Aug 2024
in Mucosal Immunity
Original Research
Accepted on 26 Aug 2024
in Biological Modeling and Simulation